Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Publications

Mass testing for discovery and control of COVID-19 outbreaks in adult social care: an observational study and cost-effectiveness analysis of 14,805 care homes in England

Lambert BEN. et al, (2025), BMJ Public Health

Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.

Nakabembe E. et al, (2025), Lancet Glob Health, 13, e81 - e97

Understanding COVID-19 testing behaviour in England through a sociodemographic lens : a population based study

Bajaj S. et al, (2024), The Lancet Digital Health

COVID-19 mass testing in adult social care in England

Chen S. et al, (2024)

Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT

Iro MA. et al, (2024), Efficacy and Mechanism Evaluation, 1 - 53

Decision to self-isolate during the COVID-19 pandemic in the UK: a rapid scoping review.

Keene CM. et al, (2024), BMJ Open, 14

Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women and their infants in Uganda and Malawi.

Hookham L. et al, (2024), PLoS One, 19

Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial.

Hill M. et al, (2023), BMJ Open, 13

Understanding COVID-19 testing behaviour in England through a sociodemographic lens

Bajaj S. et al, (2023)

Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.

Kelly E. et al, (2023), J Infect, 87, 230 - 241

SARS-CoV-2 seroprevalence in pregnant women in Kilifi, Kenya from March 2020 to March 2022.

Koech A. et al, (2023), Front Public Health, 11

A multistage mixed-methods evaluation protocol for the UKHSA testing response during the COVID-19 pandemic in England

Naidoo R. et al, (2022)

Group B Streptococcus (GBS) colonization is dynamic over time, whilst GBS capsular polysaccharides-specific antibody remains stable.

Haeusler IL. et al, (2022), Clin Exp Immunol, 209, 188 - 200

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.

Costa Clemens SA. et al, (2022), Lancet, 399, 521 - 529